Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan flag Japan · Delayed Price · Currency is JPY
5,227.00
-26.00 (-0.49%)
At close: Dec 5, 2025

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 43.02B JPY in the quarter ending September 30, 2025, with 4.11% growth. This brings the company's revenue in the last twelve months to 163.18B, down -3.33% year-over-year. In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B, down -4.53%.

Revenue (ttm)
163.18B
Revenue Growth
-3.33%
P/S Ratio
2.38
Revenue / Employee
45.14M
Employees
3,615
Market Cap
388.57B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024165.60B-7.86B-4.53%
Dec 31, 2023173.46B7.20B4.33%
Dec 31, 2022166.26B11.01B7.09%
Dec 31, 2021155.25B4.74B3.15%
Dec 31, 2020150.51B-17.54B-10.44%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Japan Tobacco 3,456.54B
Seven & i Holdings 11.55T
Ajinomoto Co. 1,525.19B
Kao Corporation 1,670.47B
Pan Pacific International Holdings 2,269.45B
Asahi Group Holdings 2,920.01B
Kirin Holdings Company 2,394.78B
Unicharm 961.15B
Revenue Rankings